Process for preparing sertraline intermediates
CA 1285574 C · Owner: Pfizer Inc. · Inventors: Quallich, George Joseph; Williams, Michael Trevelyan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A novel three-step process for preparing 4-(3,4dichlorophenyl)-4-phenylbutanoic acid is disclosed which involves (1) reducing 4-(3,4-dichlorophenyl)- 4-ketobutanoic acid to 4-(3,4-dichlorophenyl)-4hydroxybutanoic acid; (2) then converting the intermediate hydroxy acid formed in the first step to 5-(3,4-dichlorophenyl)-dihydro-2(3H)-furanone and (3), thereafter reacting the resulting gamma-butyrolactone compound with benzene in a Friedel-Crafts type reaction to form the desired final product. The latter compound is known to be useful as an intermediate leading to 4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone and ultimately, to …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted July 2, 1991. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended July 2, 2008.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.